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Summary
Here, we describe a previously unrecognized pathway
for activation of antigen-specific adaptive immune re-
sponses that was independent of Toll-Interleukin 1 Re-
ceptor signaling and directed toward detection of anti-
gens expressed by apoptotic cells. This pathway is
represented within Flt-3 Ligand-derived dendritic cells
(DCs) that represent immature lymphoid DCs, but not
within GM-CSF-treated bone marrow-derived dendritic
cells. Exposure of these DCs to apoptotic cells resulted
in production of type I interferon and favored the devel-
opment of cytotoxic T cell responses. The N-Ethyl-N-Ni-
trosourea-induced germline mutation 3d (Unc3b13d/3d)
abolished both MHC class I and II responses elicited
by this pathway,whereas anull allele ofCd36 selectively
abolishedclass II responses.Wepropose that thismode
ofadaptive immuneactivationevolved topermit thesen-
sitive detection of intracellular microbial infections,
particularly viral infections, which frequently induce
apoptotic cell death, butmay also be important in trans-
plantation, autoimmunity, and vaccine development.
Introduction
It is commonly thought that apoptosis is a bland process
that does not stimulate innate or adaptive immune re-
sponses (Gallucci et al., 1999; Blander and Medzhitov,
2004; Li et al., 2001; Steinman et al., 2000). Yet pro-
grammed cell death is induced by a variety of viral infec-
tions, and teleological reasoning suggests that the host
would benefit from exercise of a mechanism serving the
immune detection of foreign proteins expressed in the
context of a dying cell, an idea that has previously been
posed as the danger hypothesis (Matzinger, 1994). In-
deed, evidence suggests that apoptosis contributes to
the onset of an adaptive immune response either directly
(Albert et al., 1998; Finberg et al., 1979; Ronchetti et al.,
1999) or in the context of viral and/or bacterial infections
(Gorla et al., 1994; Yrlid and Wick, 2000; Winau et al.,
2006). However, the underlying mechanisms for these ob-
*Correspondence: khoebe@scripps.eduservations remain elusive. Toll-like receptors (TLRs) are
well recognized for their ability to sense molecules of
microbial origin (Akira and Takeda, 2004) and to mediate
microbial adjuvanticity (Iwasaki and Medzhitov, 2004;
Hoebe et al., 2003c; Schnare et al., 2001). It has been sug-
gested that the promiscuity of TLR receptors permits
activation not only by molecules derived from microbes
but alsobyendogenousmolecules thatmay possess sim-
ilar chemical properties (Seong and Matzinger, 2004). In
this report, however, we describe a powerful Toll/Interleu-
kin-1 Receptor domain (TIR)-independent pathway for
adaptive immune activation. This pathway senses anti-
gens expressed by cells undergoing programmed death
and depends upon specific proteins that contribute to in-
nate immune responses. It is represented within a subset
of Flt3L-induced bone marrow-derived dendritic cells
(BMDC) that, upon maturation, transform into CD8+
lymphoid-related DCs.
Results
CTL Responses Induced by Cell Death
To assess the requirements for the onset of an adaptive
immune response induced by cell death, we first estab-
lished an immunization model by using syngeneic cells
transgenic for an actin promoter-driven, membrane-
associated form of ovalbumin (act-mOVA) (Ehst et al.,
2003). C57BL/6 mice were immunized with 10 million
act-mOVA cells that were either treated with g irradiation
(1500 rad) to induce apoptosis or left untreated prior to
injection (see Figure S1 in the Supplemental Data avail-
able with this article online). After 8 days, splenocytes
were isolated from each mouse and restimulated with
OVA257-264 peptide. The frequency of antigen-specific
CD8+ T cells was determined by measuring intracellular
interferon-g (IFN-g) production as well as specific bind-
ing of OVA-H2kb tetramers, as previously described
(Hoebe et al., 2003c). In parallel, cells were restimulated
for 6 days to address their cytolytic activity and their
capacity for secondary expansion, a hallmark of T cell
memory. Although immunization with apoptotic cells
resulted in a strong IFN-g+ response in CD8+ T cells, im-
munization with nonirradiated act-mOVA cells did not
(Figure 1A). To exclude direct priming by apoptotic cells,
we immunized mice with either irradiated act-mOVA
splenocytes or act-mOVA splenocytes on a Kbm1 back-
ground to avoid direct priming via MHC class I. Both
immunizations of mice with g-irradiated (1500 rad) act-
mOVA and act-mOVA-Kbm1 splenocytes induced strong
CD8+ T cell responses as measured by the number of
CD8+IFN-g+ cells after restimulation with the OVA257-264
peptide (Figure 1B). To test whether the response
could be induced by different apoptotic stimuli, we
immunized mice with act-mOVA splenocytes that were
either UV radiated (254 nm wavelength; 240 mJ/cm2)
or treated with Fas-activating antibody (5 mg/ml). Each
protocol resulted in the development of strong cytotoxic
T lymphocyte (CTL) responses with a high frequency
of antigen-specific CD8+IFNg+ cells and efficient killing
of target cells (Figures 1C and 1D). In addition,
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788Figure 1. Apoptotic but Not Live act-mOVA Cells Induce Strong CTL Responses
(A) FACS analysis of CD8+ T cell responses after restimulation ex vivo or after secondary expansion in vitro with OVA peptide in wild-type
mice immunized with untreated act-mOVA cells or treated with act-mOVA cells rendered apoptotic through exposure to g irradiation (1500
rad). Quadrant number indicates % of antigen-specific CD8+ T cells from total cells.
(B) FACS analysis of CD8+ T cell responses after secondary expansion and restimulation of splenocytes in vitro from naive mice or mice immu-
nized with g-irradiated (1500 rad) act-mOVA or act-mOVA-Kbm-1 splenocytes. Quadrant number indicates % of total cells producing IFN-g upon
restimulation.
(C and D) CD8+ T cell responses after secondary expansion in vitro after immunization of mice with act-mOVA cells rendered apoptotic through
treatment with g irradiation (1500 rad), UV radiation (240 mJ/cm2), or Fas-activating antibody (5 mg/ml). Data in graphs represent mean6SD (n = 4
mice per group).
(E) CD8+ T cell responses ex vivo in mice immunized with g-irradiated act-mOVA, with g-irradiated wild-type splenocytes pulsed with OVA
protein (both 1500 rad), or with act-mOVA cells submitted to multiple freeze-thaw cycles (E:T ratio: 30:1). Data in graphs represent mean 6
SD (n = 4 mice per group).
(F) Splenic titers of Listeria monocytogenes after bacterial challenge with 13 105 CFU i.v. at day 8, 15, 30, and 60 after immunization. Mice were
immunized with either PBS, g-irradiated wild-type or act-mOVA splenocytes (10 million/mouse) or 1 3 103 CFU OVA-expressing L. monocyto-
genes. (Values represent mean6 SD; n = 5 for each group, *p < 0.01 difference of L. monocytogenes titers between mice treated with vehicle and
mice immunized with g-irradiated wt cells at day 8 postimmunization.)immunization of mice with g-irradiated wild-type sple-
nocytes pulsed with ovalbumin resulted in responses sim-
ilar to those observed for irradiated act-mOVA cells
(Figure 1E), whereas immunization with necrotic act-
mOVA cells or necrotic wild-type splenocytes pulsed
with ovalbumin and treated with multiple cycles of
freeze-thawing resulted in a much weaker CD8+ T cell re-
sponse (Figure 1E), indicating that necrotic cells (as op-
posed to apoptotic cells) are less efficient in inducing
a CTL response.
To assess whether this type of immunization could ini-
tiate long-term protection against pathogenic infections,
we treated wild-type C57BL/6 mice with either phos-
phate-buffered saline (PBS), irradiated splenocytes fromwild-type or act-mOVA cells, or with 1 3 103 OVA-
expressing Listeriamonocytogenes.At various days after
immunization, micewerechallengedwith13105 OVA-ex-
pressing L. monocytogenes i.v. to determine their ability
to clear the bacteria. Mice immunized with irradiated
act-mOVA cells or OVA-expressing L. monocytogenes
showed significantly reduced titers upon L. monocyto-
genes challenge up to 60 days after immunization
(Figure 1F). Compared to vehicle-treated mice, the group
immunized with wild-type irradiated splenocytes showed
significantly reduced titers at day 8 (p < 0.001) (Figure 1F),
suggesting that irradiated syngeneic cells are recognized
and induce an inflammatory response leading to antibac-
terial protection.
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(A–E) Splenocytes were untreated or treated with 120 or 240 mJ/cm2 of UV radiation. Subsequently, cells were cultured separately as monocul-
tures or as cocultures containing UV-radiated and untreated cells. At various time points, supernatants were collected and analyzed for the
presence of (A) IFN-g (24 hr of incubation) or (B) type I IFN (24 hr of incubation), as described in Experimental Procedures. CD8+ (C, D) or
CD4+ T cell (E) responses in naive or wild-type and Ifnar2/2 mice immunized with untreated or UV-treated act-mOVA cells (240 mJ/cm2) (*p <
0.001 between wt and Ifnar2/2).
(F and G) CD8+ T cell responses in wild-type and Myd882/2; Trif lps2/lps2 mice after immunization with UV-treated act-mOVA splenocytes
(240 mJ/cm2). Graphs represent mean 6 SD; 4 mice per group.
(H) Induction of type I IFN in wild-type and Myd882/2; Trif lps2/lps2 splenocytes after 24 hr exposure to nontreated or UV-treated cells (120
or 240 mJ/cm2). Values represent mean values 6 SD of three independent experiments.Apoptotic Cells Induce Type I IFN, a Key Mediator
of In Vivo CTL Responses
The mechanism of apoptotic cell sensing was investi-
gated by dividing total splenocytes into two aliquots,
one exposed to UV radiation to induce apoptosis and
the other untreated. The two populations were then cul-
tured alone or as a mixture for 48 hr, and medium was
collected and tested for cytokine production. Very low
amounts of tumor necrosis factor-a (TNF-a) (not shown)and IFN-g production (Figure 2A) were detected in all of
the cultures, but robust production of type I IFN was ob-
served after 24 hr incubation when UV-treated and un-
treated cells were cocultured (Figure 2B). We concluded
that responder cells in the untreated population sensed
apoptotic cells in the UV-treated population and pro-
duced type I IFN.
We then examined the importance of type I IFN in the
generation of CTL responses in vivo. When wild-type and
Immunity
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nized with apoptotic act-mOVA cells, the latter showed
a marked reduction in the percentage of CD8+IFN-g+ cells
(Figure 2C) as well as the ability to kill OVA-expressing tar-
get cells (Figure 2D), and CD4 T cells failed to proliferate
when exposed to MHC class II-specific OVA peptides
(Figure 2E). These results indicate that type I IFN is a key
mediator of immune responses induced by apoptotic cells.
Cell Death-Induced CTL Responses Do Not Depend
upon TLR Signaling
Because it was suggested that TLRs are essential for rec-
ognition of molecular constituents released from injured
tissues or apoptotic cells of the host (Seong and Mat-
zinger, 2004), we studied responses to apoptotic cells in
mice with homozygous mutations in both Myd88 and
Trif genes (Myd882/2 Trif lps2/lps2) (Hoebe et al., 2003a).
TLR-mediated macrophage responses to all known TLR
ligands are abolished in these mice except for dsRNA,
which is known to signal via a TLR-independent pathway
andelicits type I IFNproduction, but notTNF-aproduction
(Figures S2A–S2H; Hoebe et al., 2003c).
In MyD882/2 Trif lps2/lps2 mice, the number of
CD8+IFN-g+ T cells generated in response to immuniza-
tion with UV-treated act-mOVA cells appeared to be in-
creased compared to the number observed in wild-type
mice (Figure 2F), and both wild-type and MyD882/2
Trif lps2/lps2 mice supported the generation of equivalent
cytotoxic activity against OVA-expressing target cells
(Figure 2G). Moreover, type I IFN production was slightly
increased in splenocyte cultures from mice lacking TLR
signaling compared to wild-type mice when exposed to
UV-treated (240 mJ/cm2) splenocytes (Figure 2H). These
results effectively challenge the assumption that TLRs
are involved in cell death-induced immune responses,
and instead suggest the involvement of a previously un-
described TLR-independent pathway leading to type I
IFN production.
Flt3L-Derived B2202, but Not GM-CSF-Derived DCs,
Respond to Apoptotic Cells
Dendritic cells (DCs) and macrophages have previously
been implicated as the major cell types involved in up-
take of apoptotic cells, and DCs are potent inducers of
both CD4+ and CD8+ T cell responses. We hypothesized
that either conventional myeloid (MDCs) or plasmacytoid
DCs (PDCs) might be responsible for recognition of apop-
totic cells and subsequent type I IFN production. We
therefore generated GM-CSF-derived DCs and B220+
and B2202 Flt3 Ligand (Flt3L)-derived DCs from bone
marrow of C57BL/6 mice and examined these cells for
expression of myeloid- and lymphoid-specific markers
(Figure S3A) and for responses to CpG and LPS
(Figure S3B). We then exposed these cells to apoptotic
syngeneic splenocytes and monitored type I IFN produc-
tion over 48 hr. GM-CSF-derived DCs did not produce
substantial amounts of type I IFN, whereas B2202 and,
to a lesser extent, B220+ Flt3L-derived DCs were efficient
type I IFN producers when exposed to apoptotic cells
(Figure 3A). The type I IFN production by DCs became
apparent after 24 hr, consistent with our observations
when we used total splenocytes as responders, and
was independent of the apoptotic stimulus used. To spe-
cifically address the possibility that PDCs were able toproduce type I IFN in response to apoptotic cells, we
separated PDCs from non-PDCs by using a specific an-
tibody recognizing mouse plasmacytoid dendritic cell
antigen-1 (mPDCA-1). Whereas Flt3L-derived mPDCA12
DCs showed a similar type I IFN production as observed
for B2202DC, mPDCA1+ cells were unable to respond to
apoptotic cells (Figure S3C), suggesting that the type I
IFN response primarily depends upon Flt3L-derived
mPDCA12B2202 DCs.
In addition to the poor ability to induce CTL responses,
necrotic cells were also unable to induce type I IFN in any
of the DC subtypes (Figure 3B). Apoptotic cells obtained
after UV irradiation (240 mJ/cm2),g-irradiation (1500 rad),
or exposure to Fas-activating antibody (5 mg/ml) induced
similar amounts of type I IFN production (Figure 3C).
Flt3L-Derived B2202 DCs Acquire Apoptotic
Cell-Derived Antigen via ‘‘Nibbling’’ and
Are Highly Efficient in Crosspriming
UV-treated splenocytes were labeled with a fluorescent
marker (CFSE) and exposed to Flt3L-derived B220+
and B2202 DCs as well as GM-CSF-derived myeloid
DCs (mDCs) for 24 hr. Although GM-CSF-derived
mDCs were able to engulf apoptotic cells (Figure 3D,
Figure S3D), Flt3L-derived B2202 (Figure 3D) and
B220+ (not shown) DCs were not. However, both B2202
and B220+ Flt3L-derived DCs acquired apoptotic mate-
rial via a process that resembled ‘‘nibbling,’’ which was
observable after 24 hr of coincubation (Figure 3D and
Figure S3E). The uptake of apoptotic material could be
quantitated by FACS (Figure 3E).
The ability of each DC subtype to crossprime OT-I
CD8+ T cells was examined after 24 hr pre-exposure to
apoptotic cells that carried the act-mOVA transgene
on a C57BL/6 Kbm-1 background (thus excluding direct
activation of OT-I cells via act-mOVA cells). B2202
Flt3L-derived DCs were highly efficient in crosspriming
OT-I cells, whereas both GM-CSF- and B220+ Flt3L-de-
rived DCs induced little or no crosspriming (Figure 3F).
The same results were observed for priming of OT-II
CD4 T cells (results not shown). Coincubation of GM-
CSF-derived mDCs with irradiated act-mOVA cells in
the presence of type I IFN (Figures 4A and 4B) or
B2202 Flt3L-derived DCs that were physically separated
through transwell systems (Figure 4C) restored the abil-
ity of these mDCs to (cross-) prime OT-I and OT-II cells.
In the latter case, crosspriming of OT-I cells by GM-CSF-
derived DCs was only observed when B2202 Flt3L-de-
rived DCs were in direct contact with apoptotic cells
(Figure S4), suggesting that the apoptotic cell-derived
IFN-inducing factor is unable to pass the membrane
and therefore does not represent a soluble factor re-
leased from apoptotic cells.
To confirm crosspriming ability of these various DC
subtypes in vivo, we generated GM-CSF and Flt3L-de-
rived DCs and incubated them overnight with a 1:1 ratio
of g-irradiated act-mOVA Kbm-1 splenocytes. We then
immunized mice with 10 million (MACS isolated) DC sub-
sets i.v., and after 8 days the antigen-specific CD8+ T cell
response was analyzed ex vivo. Whereas Flt3L-derived
B220+ PDCs and GM-CSF-derived DCs induced CD8+
T cell responses that were modest at most, Flt3L-derived
B2202DCs elicited a strong CD8-specific T cell response
TLR-Independent Adjuvanticity for CTL Responses
791Figure 3. Flt3L- and GM-CSF-Derived BMDCs Respond Differently to Apoptotic Cells
(A) Type I IFN production by GM-CSF and Flt3L-derived BMDCs during a 48 hr incubation period with UV-treated wild-type splenocytes. Values
are mean 6 SD of three independent experiments.
(B) Type I IFN production in different BMDC subsets exposed to g-irradiated cells or cells subjected to multiple freeze-thawing cycles. Values
represent mean 6 SD of three independent experiments.
(C) Induction of type I IFN by BMDCs exposed to cells treated with UV radiation (120 mJ/cm2), g irradiation (1500 rad), or exposed to Fas-acti-
vating antibody (5 mg/ml). Values are mean 6 SD and depict representative experiment of three independent experiments.
(D) Uptake of UV-treated splenocytes (CFSE-labeled) by B2202 Flt3L- and GM-CSF-derived BMDCs at 6 or 24 hr of coculture as analyzed by laser
scanning confocal microscopy. Red stain represents mitochondrial activity as assessed by mitotracker red treatment.
(E) FACS analysis of GM-CSF and Flt3L-derived B2202 or B220+ DCs after 24 hr incubation with or without CFSE-labeled apoptotic (UV-treated)
splenocytes.
(F) Proliferation of CFSE-labeled OT-I cells by GM-CSF and Flt3L-derived BMDCs, pre-exposed to apoptotic act-mOVA-Kbm1 cells for 24 hr.
Proliferation was determined by FACS analysis after an additional 72 hr incubation. Data are representative of four independent experiments.and secondary expansion (Figures 4D and 4E), thus
confirming in vivo crosspriming ability of this DC subset.
Type I IFN has emerged as an important mediator for
CTL responses and costimulatory molecule expression
(Hoebe et al., 2003c; Le Bon and Tough, 2002; Montoya
et al., 2002). We therefore tested costimulatory molecule
expression on GM-CSF and B2202 Flt3L-treated bone
marrow-derived DCs after exposure to apoptotic cells.
Although CD40, CD80, and CD86 expression were in-
creased on B2202 Flt3L-derived DCs, expression was
unchanged or decreased on GM-CSF-derived DCs
(Figure S5A). Furthermore, Flt3L-derived DCs from
Ifnar2/2mice showed limited ability to activate OT-I cells
in vitro (Figure S5B), suggesting that type I IFN acts on
DCs in an autocrine and/or paracrine manner indepen-
dent of T cells. Finally, addition of type I IFN directly
induced costimulatory molecule expression on Flt3L-de-
rived B2202 DCs (Figure S5C), confirming the important
role of type I IFN in priming DCs ultimately leading to effi-
cient T cell activation.
Maturation of Flt3L-Derived B2202CD82 DCs into
B2202CD8+ Lymphoid-Related DCs
CD8+ but not CD82B2202 DCs have previously been
shown to be the principal DC subset involved in CTLresponses in the context of viral infections, i.e. HSV
type 1, influenza, and vaccinia virus infections, as well
as bacterial infections (Belz et al., 2004, 2005; Smith
et al., 2003). They have been shown to elicit CTL re-
sponses to antigens administered in the context of
cell death (den Haan et al., 2000). We therefore followed
maturation of GM-CSF and Flt3L-derived DC subsets
upon exposure to TLR ligands. Whereas all subtypes
showed upregulation of CD40, CD80, MHC class I, and
the activation marker CD69, CD8a expression was
highly induced on Flt3L-derived B2202 DCs and to
some degree on GM-CSF-derived DCs (Figure 5A).
Based on these results, we concluded that Flt3L-derived
CD82B2202DCs represent immature precursors of con-
ventional CD8+ lymphoid-related DCs.
We next confirmed the crosspriming ability of lym-
phoid-related DC subsets ex vivo by isolating phenotyp-
ically identical dendritic cells directly from the spleen.
CD11b2CD11c+ DCs were isolated from spleen by means
of MACS and sorted based on their MHC II, CD8, and/or
B220 expression (Figure S5D). While CD82B220+ and
CD8+B220+ cells were unable to stimulate crosspriming
afterexposure toapoptoticact-mOVAcells, the immature
CD82B2202 and mature CD8+B2202 DCs were both
highly efficient in activating CD8+ OT-I cells (Figure 5B),
Immunity
792Figure 4. Flt3L-Derived B2202 DCs Efficiently Activate CD8+ and CD4+ T Cells and Can Serve as Bystander Cells
(A and B) Flt3L- and GM-CSF-derived DCs were exposed to UV-treated (240 mJ/cm2) act-mOVA-Kbm1 splenocytes 24 hr in the presence or
absence of IFN-b, prior to the addition of CFSE-labeled (A) OT-I CD8+ T cells or (B) OT-II CD4+ T cells. Proliferation was determined after 72
hr incubation by FACS analysis. Experiments were performed in triplicate and data are representative of at least three independent experiments.
Histogram numbers represent the percentage of responding cells.
(C) Rescue of GM-CSF-derived (cross-) priming of OT-I CD8+ or OT-II CD4+ T cells when cocultured with Flt3L-derived B2202 BMDCs on a
wild-type, MHC I-deficient, and MHC II-deficient background, either cultured in direct or indirect contact via a transwell system. In the latter,
TLR-Independent Adjuvanticity for CTL Responses
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marrow-derived Flt3L-treated DCs. Together, these find-
ings suggest that both immature and mature lymphoid
DCs act either directly or as a source of type I IFN to
induce CTL responses stimulated by apoptotic cells.
Involvement of Unc93b1 and Cd36 in CD4
and CD8 Responses
Among numerous ENU-induced mutations known to af-
fect innate immune responses, two exhibited impressive
inhibitory effects on adaptive responses induced by ap-
optotic cells.Oblivious, a nonsense allele ofCd36 known
to impair sensing of microbial diacylglycerides (Hoebe
et al., 2005), abrogated CD4 responses, but not CD8
responses, in homozygous mutant mice (Figures 6A–
6C). This mutation had no effect on type I IFN production
(Figure 6D). The 3d allele of Unc93b1, which encodes
UNC-93B, a 12-spanning ER membrane protein required
for responses to TLR3, 7, and 9 ligands (Tabeta et al.,
2006), abrogated both CD8+ and CD4+ T cell responses
in homozygotes (Figures 6B and 6C). Again, type I IFN
production was unaffected (Figure 6D). Neither mutation
affected the uptake of apoptotic cells by GM-CSF- or
Flt3L-derived DCs (Figure S6A and data not shown) or
decreased expression of MHC class I or class II antigens
on the cell surface (Figure S6B and data not shown).
However, crosspriming of OT-I CD8+ cells was abro-
gated, and reduced priming of OT-II CD4+ cells was ob-
served inUnc93b13d/3d mice (Figure 6E). Additional stud-
ies with antibodies specific for the OVA-MHC I complex
showed that Unc93b13d/3d mice were defective in MHC
class I antigen presentation when exposed to either ap-
optotic act-mOVA cells (Figures 6G and 6F) or soluble
ovalbumin (Tabeta et al., 2006). Finally, Unc93b13d/3d
DCs directly loaded with low concentrations of OVA pep-
tides were able to (cross-) prime OT-I or OT-II cells
(Figure S6C). Together, these findings suggest that the
defect observed in Unc93b13d/3d mice is related to de-
fective antigen processing rather than recognition or up-
take of apoptotic cells.
Discussion
TLRs mediate many and perhaps most phenomena as-
sociated with microbial infections, including the well-
known immunoadjuvant effect of infection. However,
mice that are incapable of TIR signal transduction
have grossly normal lymphoid tissues, produce IgG,
and are capable of allograft rejection (unpublished ob-
servations), indicating that TLRs are not obligatory for
adaptive immune responses per se. We show herein
that apoptotic cells trigger an innate and subsequent
adaptive immune response that is independent of TIR
signaling. Of key importance in this pathway is the rec-
ognition of apoptotic cells by (precursor) lymphoid
DCs and their concomitant production of type I IFN.Type I IFN is an important mediator of adjuvanticity via
TIR-dependent pathways (Hoebe et al., 2003c; Le Bon
et al., 2003), and, as shown here, is also a central medi-
ator of adjuvanticity elicited by apoptotic cells, but via
a TIR-independent pathway. Diverse subsets of DCs
with specialized functions have been described (Liu,
2005; Shortman and Liu, 2002). Among them, pDCs are
thought to be specialized type I IFN-producing cells dur-
ing viral infections, yet clearly myeloid or conventional
DCs can serve a similar function utilizing alternative sig-
naling pathways (Asselin-Paturel and Trinchieri, 2005;
Kato et al., 2005). The current data suggest that produc-
tion of type I IFN induced by cell death depends on
direct recognition of dying cells by (precursor) lymphoid
DCs and not by pDCs, whereas the removal of apop-
totic cells primarily depends upon GM-CSF-derived or
mDCs. In addition, immature lymphoid DCs are capable
of ‘‘sampling’’ apoptotic cells through ‘‘nibbling’’ and are
highly efficient in crosspriming CD8+ T cells.
Several triggers of apoptosis are capable of initiating
events that lead to a strong adaptive immune response.
CTL responses were elicited with act-mOVA cells ren-
dered apoptotic via UV or g irradiation and also after
treatment with Fas-activating antibodies. The latter
effect implicates an apoptotic pathway that is intimately
involved in immune responses. Fas receptor is ex-
pressed on many cell types in different organs and in-
duces apoptosis via a caspase-dependent mechanism
(Barnhart et al., 2003). The engagement of Fas with its
cognate ligand (FasL) is used by virtually every effector
immune cell that is activated to mediate cytotoxicity to-
wards infected cells or tumor cells (Dennert, 2002; Smyth
et al., 2005). In addition, many viruses or bacteria can di-
rectly induce apoptosis that can lead to inflammatory
responses. The TLR-independent pathway therefore
may detect intracellular infections and also aids the de-
velopment of CTL responses when cell death occurs
via NK cells or T cell-mediated cytotoxicity. Recent stud-
ies report that both dsRNA and mammalian DNA induce
type I IFN via TLR-independent pathways (Ishii et al.,
2006; Kato et al., 2005; Okabe et al., 2005; Yoneyama
et al., 2004). However, these pathways are present in
conventional myeloid DCs, which we show here are de-
ficient in type I IFN production upon exposure to apopto-
tic cells. Furthermore, we found no effect on apoptotic
cell-mediated type I IFN production in the presence of
DNase I and/or RNase (results not shown). These obser-
vations suggest that the production of type I IFN is inde-
pendent of DNA and RNA, yet the possibility that these
nucleotide structures enter the cytosol directly without
exposure to the extracellular environment cannot be
excluded.
Although not all of the molecular components of the
death-induced immunoadjuvant pathway are known,
we have shown that CD36 and UNC-93B both contribute
to CD4+ T cell priming, while UNC-93B is required forboth top and bottom wells contain apoptotic act-mOVA cells, with top wells containing Flt3L-derived B2202BMDCs and bottom wells containing
GM-CSF-derived DCs and OT-I CD8 or OT-II CD4 T cells. Control experiments include apoptotic act-mOVA cells in the bottom or top well only
(Figure S3). Experiments were performed in triplicate and data are representative for at least three independent experiments. Histogram numbers
represent the percentage of responding cells.
(D and E) Immunization of C57BL/6 mice with 10 million GM-CSF- or Flt3L-derived B220+ and B2202DC subsets exposed for 24 hr to g-irradiated
act-mOVAKBm-1 splenocytes. After 8 days, the antigen-specific CD8+ T cell response was determined after ex vivo restimulation with SIINFEKL
and measurement of the % CD8+IFN-g+ T cells (D) and their ability to proliferate after exposure to OVA-expressing EL-4 cells in vitro (E). Values
are mean values 6 SD (n = 4 mice per group).
Immunity
794Figure 5. TLR-Induced Maturation of Flt3L-Derived B2202 DCs Results in Upregulation of CD8a
(A) Surface expression of CD8, CD69, MHC class I, CD80, and CD40 on GM-CSF- and Flt3L-derived DC subsets after treatment withLPS (100 ng/ml)
or CpG (10 mM) for 4 hr (red) or 24 hr (black) or left untreated (blue).
(B) Proliferation of CFSE-labeled CD8+ OT-I T cells after exposure to various lymphoid and plasmacytoid related DC subsets directly isolated from
spleen and cultured in the presence of g-irradiated wild-type Kbm1 or act-mOVA-Kbm1 splenocytes.crosspriming of CD8+ T cells. Neither protein is required
for type I IFN production; hence, neither is solely re-
quired for sensing apoptotic cells. In the intact Cd36obl
environment, MHC class II priming, measured by OT-II
proliferation, occurs normally in response to apoptotic
cells (E.J. and K.H., unpublished data). This suggeststhat CD36 fulfills a role related to the primary expansion
of antigen-specific CD4+ T cells, but is not required for
MHC class II priming per se. The role of CD36 as a sensor
of diacylglycerides (Hoebe et al., 2005) may imply that
a lipid component of apoptotic cells supports this ex-
pansion and that CD36 mediates this effect through
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(A and B) Wild-type (wt), Cd36obl/obl, and Unc93b13d/3d mice were immunized with UV-treated act-mOVA splenocytes and analyzed after sub-
sequent secondary expansion in vitro for the frequency of (A) CD8+IFN-g+ cells in response to SIINFEKL, as well as (B) their ability to kill pep-
tide-pulsed EL4 target cells (*p < 0.001 between act-mOVA immunized wt and Unc93b13d/3d mice). Values are mean6 SD (n = 4 mice per group).
(C) CD4+ T cell proliferation in wild-type, Cd36obl/obl, and Unc93b13d/3d mice immunized with apoptotic act-mOVA cells. Values are mean 6 SD
(n = 4 mice per group). (#p < 0.0001 between C57BL/6 and Cd36obl/obl or Unc93b13d/3d proliferation.)
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796a TLR-independent process. As for UNC-93B, its diverse
functions in immunity include support of signaling via
endosomal TLRs (3, 7, 8, and 9) as well as MHC antigen
presentation leading to (cross-) priming of CD8+ and
CD4+ T cells (Tabeta et al., 2006). The exact mechanism
whereby it exerts these effects has yet to be deciphered.
Autoamplification loops, based upon the binding of
pre-existing immune complexes either to B cells (via
TLR-dependent but also -independent pathways)
(Boule et al., 2004; Lau et al., 2005; Martin and Elkon,
2005;Vollmer et al., 2005; Leadbetter et al., 2002; Barrat
et al., 2005) or to PDCs (via FcgRIIa) (Bave et al., 2003;
Lovgren et al., 2004) have been proposed as a funda-
mental mechanism in systemic lupus erythrematosus
(SLE), the prototypic systemic autoimmune disease. In
the former case, the adaptive immune response was de-
pendent upon TLR activation, while the latter was ac-
companied by type I IFN production. The death-driven
immunoadjuvant pathway described here may also am-
plify the autoimmune response in SLE, a view consistent
with defects in removal of apoptotic bodies (Herrmann
et al., 1998), the existence of a type I IFN ‘‘signature’’
in blood cells and afflicted tissues of patients, and the
requirement for type I IFN in some spontaneous models
of this disease (Theofilopoulos et al., 2005). As such, it
would represent a proximal autoimmune pathway that
could function independent of pre-existing autoanti-
bodies. Mutations that alter the normal pattern of cell
death, impair the removal of apoptotic cells, or enhance
immune perception of apoptotic cells might be primary
contributors to autoimmunity. Moreover, interruption
of the apoptotic cell-induced immune response might
have a substantial mitigating effect in autoimmune
disease.
Experimental Procedures
Mice and Materials
All experiments were performed according to the US National Insti-
tutes of Health guidelines. C57BL/6 wild-type, CD36obl/obl,
unc93b13d/3d mutant, OT-I, OT-II, and MyD882/2; Trif lps2/lps2 dou-
ble-deficient mice were bred on a C57BL/6 background and housed
in the Scripps Research Institute Vivarium. All knockout mice used
in the experiments were transferred on a C57BL/6 background after
repeated backcrossing to C57BL/6 mice (at least 6 times). IFNAR
knockout mice were kindly provided by Dr. Jonathan Sprent (The
Scripps Research Institute, La Jolla, CA), and act-mOVA transgenic
mice were a kind gift from Dr. Mark Jenkins (University of Minnesota
Medical School, Minneapolis, MN) and were bred onto a Kbm1 back-
ground.
Escherichia coli RE595 LPS was obtained from Alexis (San Diego,
CA), and dsRNA (poly (I:C)) was obtained from Amersham Pharma-
cia Biotech (Piscataway, NJ). Resiquimod was a kind gift from No-
vartis (Basel, Switzerland). PAM3CSK4 and Malp2 were obtained
from EMC microcollections GmbH (Tu¨bingen, Germany). Phosphor-
othioate-stabilized CpG oligodeoxynucleotide (CpG ODN) 50-TCC-
ATG-ACG-TTC-CTG-ATG-CT-30 was obtained from Integrated
DNA Technologies (Coralville, IA). Zymosan A was obtained from
Sigma (St. Louis, MO). Fluorescent-labeled antibodies directedagainst IFN-g, CD11b, CD11c, MHC-II, B220, CD4, and CD8 were
obtained from eBioscience (San Diego, CA), and microbeads for
negative selection of CD4 and CD8 T cell and positive selection of
B220, mPDCA-1, and CD11c were obtained from Miltenyi Biotec
(Auburn, CA). Human Flt3 Ligand was purchased from Preprotech,
Inc. (London, UK), and GM-CSF was from Becton Dickinson (Frank-
lin Lakes, NJ). CFSE and mitotracker Red CM-H2XRos were ob-
tained from Molecular Probes (Eugene, OR). Ovalbumin-specific
peptide for MHC class I (OVA257-264: SIINFEKL) or MHC class II
(OVA323-339; ISQAVHAAHAEINEAGR) were purchased from A&A
Labs LLC (San Diego, CA).
Immunization and Listeria monocytogenes Challenge
The experiments involving immunizations and challenges with Liste-
ria monocytogenes were performed as detailed elsewhere (Brock-
stedt et al., 2005). In brief, five 6- to 8-week-old C57BL/6 male
mice per group were subcutaneously injected either with 200 ml
PBS, with 200 ml irradiated splenocytes from wild-type or act-
mOVA cells (1 3 107 in 200 ml), or with 200 ml containing 1 3 103
CFU of OVA expressing Listeria monocytogenes. Subsequently,
mice were challenged with 1 3 105 OVA expressing L. monocyto-
genes i.v. at day 8, 15, or 30 postimmunization. After 3 days, spleens
were isolated and the L. monocytogenes titer was determined after
homogenization of total spleens in 5 ml dissociation buffer contain-
ing dH2O (GIBCO) + 0.2% NP-40 (Sigma-Aldrich). Series of 10-fold
dilutions in PBS were prepared and 100 ml of each dilution was
plated onto bacterial culture plates containing Brain Heart Infusion
agar + 200 mg/mL streptomycin (Difco). After additional 24 hr incuba-
tion at 37ºC, the numbers of colonies were counted to determine the
splenic titer.
Induction of Cell Death
Splenocytes were isolated via collagenase and a cell strainer (70 mM)
and subsequently washed in Iscove’s modified Dulbecco’s medium
(IMDM) supplemented with 10% FCS, 2% penicillin/streptomycin
(Invitrogen, San Diego, CA) and 50 mM b-mercaptoethanol (Sigma)
followed by lysis of erythrocytes via red blood cell lysing buffer
(Sigma). Cells were subsequently brought to a concentration of
10 3 106 cells/ml in medium and were either left untreated or
rendered apoptotic through exposure to either g irradiation (1500
Rad), UV irradiation (240 mJ/cm), or Fas-activating antibody (5 mg/
ml). For treatment with Fas-activating antibody, splenocytes were in-
cubated at 37ºC and 5% CO2 for 2 hr, followed by two thorough wash-
ings with medium and one wash with PBS. Alternatively, cells were
rendered necrotic through 5 cycles of freeze-thawing at 280ºC in
PBS. The induction of apoptosis/necrosis was analyzed by flow cy-
tometry via annexin V and propidium iodide as apoptotic/necrotic
markers. Cells used for immunization were washed once with PBS
and resuspended in PBS at a concentration of 5 3 107 cells/ml.
Each mouse was injected s.c. with 200 ml cell suspension.
Cytokine Measurements
To measure cytokine responses in vitro, either total splenocytes (53
105/well) or 53 104 DCs/well in a 96-well plate were cocultured with
5 3 105 cells/well of UV- or g-irradiated cells for 24 hr. Control cul-
tures included 106 cells/well of apoptotic or nontreated cells. After
24 hr, supernatants were collected and cytokines measured by bio-
assays or ELISAs. TNF-a production was measured via the L929 bio-
assay as previously described (Hoebe et al., 2003b). The concentra-
tion of type I IFN was determined by means of a cell line containing
an ISRE-responsive element luciferase reporter construct as de-
scribed elsewhere (Jiang et al., 2005). Production of IFN-gwas mea-
sured by a commercial ELISA (R&D Biosystems, Minneapolis, MN).(D) Induction of type I IFN in wild-type,Cd36obl/obl, andUnc93b13d/3d splenocytes after 24 hr exposure to untreated or UV-treated cells (120 or 240
mJ/cm2). Values represent mean values 6 SD of three independent experiments.
(E) Activation of CFSE-labeled OT-I and OT-II T cells by B2202 Flt3L-derived DCs from wild-type and Unc93b13d/3d mutant mice pre-exposed to
apoptotic act-mOVA-Kbm-1 cells for 24 hr. Proliferation was determined by FACS analysis after an additional 72 hr incubation.
(F and G) GM-CSF and Flt3L-treated B2202 BMDCs from Unc93b13d/3d mice show abrogated MHC/SIINFEKL-complex formation. DCs were
incubated for 24 hr with g-irradiated act-mOVA-Kbm-1 splenocytes. Formation of MHC class I-SIINFEKL-complex was determined via a specific
antibody, as described in Experimental Procedures. Values are mean 6 SD from triplicate values and graph is representative of three indepen-
dent experiments.
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Responses
Induction of cytolytic T lymphocyte responses via subcutaneous in-
jection of apoptotic cells has been extensively described (Finberg
et al., 1979; Huang et al., 1996; Janssen et al., 2003, 2005). In brief,
mice were immunized with act-m-OVA splenocytes that were either
left untreated or rendered apoptotic through exposure to either g ir-
radiation (1500 Rad), UV irradiation (240 mJ/cm), or Fas-activating
antibody (5 mg/ml). Mice were immunized subcutaneously with
10 3 106 cells in PBS. Alternatively, mice were immunized with
equivalent volume/numbers of necrotic cells obtained through mul-
tiple cycles (5 times) of freeze-thawing (280ºC) in PBS. After 7 days,
spleens were isolated and single-cell suspensions were made in
IMDM supplemented with 10% FCS, 2% penicillin/streptomycin,
and 50 mM b-mercaptoethanol. The frequency of OVA-specific
CD8+ T cells was determined after OVA257-264-K
b tetramer staining
or by intracellular IFN-g staining upon 5 hr incubation with OVA257-264
(5 mg/ml) in the presence of Brefeldin (Janssen et al., 2003, 2005).
To study the cytolytic capacity of the CD8+ T cells, splenocytes
were cultured with irradiated MEC.B7.Sig-OVA cells (1:10) for 6
days. Restimulated splenocytes were evaluated by JAM test as
previously described (Janssen et al., 2003), by means of 3[H]thymi-
dine-labeled EL-4 cells loaded with OVA257-264 or control peptide.
Specific killing was calculated as follows: (spontaneous c.p.m. 2
experimental c.p.m.) 3 100/spontaneous c.p.m. The proliferative
capacity of OVA-specific CD4+ T cells was determined by standard
lymphocyte stimulation assay. In brief, splenocytes were cultured in
96-well plates (2 3 106 cells/well) with medium or increasing doses
of OVA323-339 for 72 hr, after which the cells were pulsed for 8 hr
with 3[H]thymidine (0.1 mCi/well). Proliferation was calculated by
dividing the incorporated c.p.m. of the OVA323-339-stimulated cells
by the c.p.m. of medium-stimulated cells.
Generation of DC Subsets and T Cell Purification
BM cells were isolated and cultured with Flt3L (200 ng/ml) or with
GM-CSF (20 ng/ml) as previously described (Brasel et al., 2000;
Lutz et al., 1999). After 8 days, DCs were sorted in subpopulations
based on their expression of B220 and CD11c or expression of
mouse plasmacytoid dendritic cell antigen-1 (mPDCA-1) by MACS
microbeads. DCs were thoroughly analyzed for surface marker ex-
pression and cytokine expression upon TLR ligation. Purity of all
the different populations was >97%. OT-I (CD8+) and OT-II (CD4+)
T cells were isolated by negative selection by T cell isolation kits
(Miltenyi) and labeled with CFSE as described previously (Tabeta
et al., 2006).
Determination of Priming and Crosspriming by Different DC
Subsets
To determine the ability of DC subsets to prime purified CFSE-la-
beled OT-I or OT-II T cells, we cultured different DC subsets in
IMDM (supplemented with 10% FCS, 2% penicillin/streptomycin,
50 mM b-mercaptoethanol) at a concentration of 1 3 106 cells/well
in the presence or absence of 3 3 106 UV-treated act-mOVA cells
(240 mJ/cm2) on a Kbm1 background (to avoid direct presentation
of act-mOVA cells to T cells). In addition, different DC subsets
were cultured either in direct or indirect contact with apoptotic
act-mOVA cells via 0.02 mm Anapore membrane Tissue culture
inserts (Nalgene Nunc International, Rochester, NY). Cells were in-
cubated at 37ºC, 5% CO2, and after 24 hr incubation, either 2 3
105 CFSE-labeled OT-I or OT-II T cells were added to each well. After
an additional 72 hr of incubation, CFSE intensity of OT-I or OT-II cells
was determined by flow-cytometry analysis with specific fluores-
cent-labeled antibodies for CD4 or CD8 in combination with Va2.
In addition, OT-I or OT-II T cells were cultured alone or in the pres-
ence of act-mOVA/Kbm1 cells as negative controls, or with CD4- or
CD8-specific OVA peptides as a positive control.
Isolation of DC Subsets from Spleen
Spleens were treated with 2 mg/ml of collagenase D (Roche Diag-
nostics, Germany) in 10 mM HEPES-NaOH, 150 mM NaCl, 5 mM
KCl, 1 mM MgCl2, 1.8 mM CaCl2 to obtain a single-cell suspension.
Subsequently, splenocytes were washed with PBS containing 0.5%
FBS and 2% EDTA, and CD11b2/CD11c+ cells were isolated with
microbeads (Milteny Biotec, Auburn, CA). After 15 min incubation,cells were washed and separated by means of a LS MACS column.
Subsequently, DCs were labeled with fluorochrome-conjugated an-
tibodies specific for MHC-II, CD8, and B220 and directly separated
by FACS sort. CD11b2/CD11c+ DCs were sorted based on MHC
class II+ and CD8 and B220 surface expression, and CD8+/B220+,
CD82/B220+, CD8+/B2202, and CD82/B2202 DC subsets were
collected and exposed to g-irradiated act-mOVA-Kbm-1 cells. OT-I
and OT-II proliferation was assessed as described above.
Immunostaining of SIINFEKL/Kb Complex
Bone marrow-derived GM-CSF and B2202 Flt3L-treated DCs from
wild-type and 3d mice were cocultured in the presence of g-irradi-
ated act-mOVA splenocytes (at various ratios). After 24 hr, cells
were stained with Alexa Fluor-750 coupled mAb 25-D1.16 specifi-
cally recognizing the SIINFEKL/Kb complex (Porgador et al., 1997).
Statistical Analysis
All experiments were repeated at least three times, and comparison
between groups was performed by one-way analysis of variance
(ANOVA).
Supplemental Data
Supplemental Data include six figures and two movies and can be
found with this article online at http://www.immunity.com/cgi/
content/full/24/6/787/DC1/.
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